Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akcea Therapeutics
Akcea Therapeutics
(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tegsedi
Inotersen
2018-10-05
2025-2031
Amyloidosis
,
Familial amyloid neuropathies
Waylivra
Volanesorsen
2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
amyloidosis
,
familial amyloid neuropathies
,
pregnancy
Pelacarsen
renal insufficiency
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
healthy volunteers/patients
,
hypertriglyceridemia
,
hyperlipidemias
,
hyperlipoproteinemias
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
dyslipidemias
,
homozygous familial hypercholesterolemia
Endocrine
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
lung neoplasms
,
head and neck neoplasms
,
neoplasms by site
,
brain neoplasms
,
thyroid neoplasms
,
respiratory tract diseases
,
central nervous system neoplasms
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
colonic neoplasms
,
papillary thyroid cancer
,
endocrine gland neoplasms
,
thyroid diseases
,
medullary carcinoma
,
bronchial neoplasms
,
melanoma
,
sarcoma
,
myofibromatosis
,
ovarian neoplasms
,
endometrial neoplasms
,
squamous cell carcinoma of head and neck
,
uterine cervical neoplasms
,
breast diseases
,
hereditary sensory and autonomic neuropathies
,
obesity
,
type 2 diabetes mellitus
,
diabetes mellitus
,
endocrine system diseases
,
glucose metabolism disorders
,
metabolic diseases
,
male breast neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
breast neoplasms
,
neoplasms
,
neoplasm metastasis
,
triple negative breast neoplasms
,
type 1 diabetes mellitus
,
growth disorders
,
dwarfism
Trinessa
healthy volunteers/patients
,
coronary artery disease
,
electrocardiography
,
overactive urinary bladder
,
endometriosis
,
cough
,
hot flashes
,
multiple endocrine neoplasia type 1
,
tuberculosis
,
infections
,
communicable diseases
,
intraabdominal infections
,
abdominal abscess
,
pelvic infection
,
pelvic inflammatory disease
,
diabetic foot
,
wound infection
,
ulcer
,
aspiration pneumonia
,
lung abscess
,
contraception
,
sepsis
,
septic shock
,
respiratory tract infections
,
lung diseases
,
acute cholecystitis
,
chronic bronchitis
,
pneumonia
,
bronchitis
,
sinusitis
,
abscess
,
community-acquired pneumonia
,
acute disease
,
liver abscess
,
pyogenic liver abscess
,
maxillary sinusitis
,
bacterial infections
,
rhinosinusitis
,
disease progression
,
wounds and injuries
,
chemical and drug induced liver injury
,
tonsillitis
,
peritonitis
,
bacterial skin diseases
,
bronchial diseases
Fluoroquinolone
cardiovascular abnormalities
Thienopyridine
cardiovascular diseases
Tqj230
liver diseases
,
hepatic insufficiency
,
healthy volunteers/patients
,
aortic valve stenosis
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
,
myocardial infarction
,
atherosclerosis
,
stroke
,
acute coronary syndrome
,
dyslipidemias
,
inflammation
,
infarction
,
genetic polymorphism
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use